These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1982831

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A, Paoletti E, Molinelli G.
    Adv Perit Dial; 1990; 6():292-5. PubMed ID: 1982830
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Chung WW, Leung CB, Chan K, Lai KN.
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK, Cy C, Chan MK, Yu L, Fang GX, Wei D.
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [Abstract] [Full Text] [Related]

  • 6. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Law CB, Ting SM, Li P, Lai KN.
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [Abstract] [Full Text] [Related]

  • 9. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C, Blumberg A.
    Schweiz Med Wochenschr; 1990 Feb 17; 120(7):217-20. PubMed ID: 2309110
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic and pharmacodynamic studies on recombinant human erythropoietin.
    Salmonson T.
    Scand J Urol Nephrol Suppl; 1990 Feb 17; 129():1-66. PubMed ID: 2255869
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin.
    Barclay PG, Fischer ER, Harris DC.
    Clin Nephrol; 1993 Nov 17; 40(5):277-80. PubMed ID: 8281716
    [Abstract] [Full Text] [Related]

  • 13. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr 17; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 14. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F, Herrero JA, Montenegro J, Fernandez C, Gandara A, Conesa J, Rivera MT, Torrente J, Portolés J, Gomez-Martino JR.
    J Nephrol; 2003 Apr 17; 16(5):697-702. PubMed ID: 14733416
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
    Zelichowski G, Lubas A, Sienkiewicz M, Janusz E, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr 17; 24(142):312-5. PubMed ID: 18634362
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of anemia in patients after long term hemodialysis with human recombinant erythropoietin].
    Boratyńska M, Mazanowska O, Szewczyk Z.
    Pol Merkur Lekarski; 1996 Nov 17; 1(5):329-31. PubMed ID: 9273209
    [Abstract] [Full Text] [Related]

  • 17. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC, Lee EJ.
    Adv Perit Dial; 1991 Nov 17; 7():285-7. PubMed ID: 1680447
    [Abstract] [Full Text] [Related]

  • 18. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Nov 17; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 19. Peritoneal dialysis efficiency in CAPD patients in treatment with rHuEPO.
    Vega N, Fernandez A, Hortal L, Macias M, Rodriguez JC, Plaza C, Perdomo M, Vega R, Palop L.
    Adv Perit Dial; 1992 Nov 17; 8():467-70. PubMed ID: 1361850
    [Abstract] [Full Text] [Related]

  • 20. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R, Besarab A, Macdougall IC, Ellison DH, Maxwell AP, Sulowicz W, Klinger M, Rutkowski B, Correa-Rotter R, Dougherty FC, BA 16528 Study Investigators.
    Clin Nephrol; 2007 May 17; 67(5):306-17. PubMed ID: 17542340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.